Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc.: 2 recalls listed since July 2026 across FDA.

By year

20262

By agency

FDA2

By category

Drug2

All recalls (2)

FDA•Sep 3, 2026LOW
Trokendi XR (topiramate) Extended-Release Capsules
Trokendi XR (topiramate) 50 mg capsules recalled over failed dissolution specs.
FDA•Jul 17, 2026LOW
Trokendi XR Topiramate ER Capsules 25mg
Supernus recalls Trokendi XR 25mg capsules over failed dissolution specs.
3 products